AML or MDS
Item
patients should have aml or mds according to new who classification, with minimum of 5% blasts in peripheral blood.
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
Treatment history
Item
there must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
boolean
C0087111 (UMLS CUI [1])
Prior treatment
Item
prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
boolean
C0087111 (UMLS CUI [1])
Bone marrow
Item
adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
boolean
C0005953 (UMLS CUI [1])
Further restrictions
Item
there are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. although aml is rare in children, pediatric patients will be accepted.
boolean
C0700589 (UMLS CUI [1])
Deficiency of g6pd
Item
there is no deficiency of g6pd (rbc).
boolean
C0391941 (UMLS CUI [1])
Disease characteristics
Item
asymptomatic patients with disease progression and symptomatic patients.
boolean
C0242656 (UMLS CUI [1])